Assessing Risk Level of Patients With Myelofibrosis

To determine risk level in myelofibrosis, prognostic models are used which assign points to various clinical and pathological factors to calculate a risk score that categorizes patients as low, intermediate, or high risk; additional information like mutations and chromosomes can further refine risk stratification.

CML Alliance
Enable registration in settings - general
Compare items
  • Total (0)
Shopping cart